Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Thromb Res. 2020 Apr 23;191:42–49. doi: 10.1016/j.thromres.2020.03.025

Table 6.

Multivariable Predictive Model (white lines) and Internal Validation Model (gray lines) using Table 4 (not inclusive of thromboembolic disorder)

Predictor Variable Adjusted OR (95% CI) p-value
Mode of delivery (cesarean vs vaginal delivery) 1.86 (1.21 – 2.85) <0.001*
1.86 (1.79 – 1.94) <0.001*
BMI (admission) per 5 unit increase 1.25 (1.09 – 1.42) <0.001*
1.22 (1.21 – 1.24) <0.001*
Gestational age, per 1 week increase 0.93 (0.87 – 0.99) 0.014*
0.93 (0.92 – 0.93) <0.001*
Pre-gestational diabetes 2.31 (1.21 – 4.42) 0.011*
2.36 (2.22 – 2.50) <0.001*
Chronic heart disease 3.87 (1.86 – 8.06) <0.001*
3.82 (3.58 – 4.09) <0.001*
Preeclampsia 1.71 (1.01 – 2.90) 0.046*
1.70 (1.62 – 1.79) <0.001*
Blood transfusion (intrapartum or postpartum) 3.18 (1.74 – 5.83) <0.001*
3.25 (3.08 – 3.43) <0.001*
Drug use during pregnancy 2.87 (1.29 – 6.42) 0.010*
2.95 (2.75 – 3.17) <0.001*
Postpartum maternal length of stay, per 1 day increase 1.07 (1.05 – 1.09) <0.001*
1.07 (1.06 – 1.07) <0.001*
*

p<.05, statistically significant